Your browser doesn't support javascript.
loading
Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.
Giles, Thomas D; Weber, Michael A; Basile, Jan; Gradman, Alan H; Bharucha, David B; Chen, Wei; Pattathil, Manoj.
Afiliação
  • Giles TD; Department of Medicine, Tulane University, New Orleans, LA, USA. Electronic address: tgiles4@cox.net.
  • Weber MA; Division of Cardiovascular Medicine, State University of New York, Downstate College of Medicine, Brooklyn, NY, USA.
  • Basile J; Department of Medicine, Division of Cardiology, Medical University of South Carolina, Charleston, SC, USA.
  • Gradman AH; Department of Medicine, Temple University School of Medicine, Pittsburgh, PA, USA.
  • Bharucha DB; Department of Clinical Development, Forest Research Institute, Jersey City, NJ, USA.
  • Chen W; Department of Biostatistics, Forest Research Institute, Jersey City, NJ, USA.
  • Pattathil M; Department of Clinical Development, Forest Research Institute, Jersey City, NJ, USA.
Lancet ; 383(9932): 1889-98, 2014 May 31.
Article em En | MEDLINE | ID: mdl-24881993
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tetrazóis / Valina / Benzopiranos / Etanolaminas / Hipertensão / Anti-Hipertensivos Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: Lancet Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tetrazóis / Valina / Benzopiranos / Etanolaminas / Hipertensão / Anti-Hipertensivos Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: Lancet Ano de publicação: 2014 Tipo de documento: Article